Pure Biologics SA Sustainability Reports
Pure Biologics S.A. is a Polish biopharmaceutical company focused on the research and development of innovative biological drugs and extracorporeal therapies. The company specializes in identifying and developing novel therapeutic molecules, such as antibodies and aptamers, primarily for applications in immuno-oncology and rare diseases.
Sector: Professional & technical services
Country: Poland
Exchange: Warsaw Stock Exchange
LEI: 2594002TXS19AUYHIF82
FIGI: BBG00MS3WV46
No reports are currently available in our catalogue.